Afficher la notice abrégée

dc.contributor.authorMartínez-Campelo, Laura
dc.contributor.authorCruz, Raquel
dc.contributor.authorBlanco-Verea, Alejandro
dc.contributor.authorMoscoso, Isabel
dc.contributor.authorRamos-Luis, Eva
dc.contributor.authorLage, Ricardo
dc.contributor.authorÁlvarez-Barredo, María
dc.contributor.authorSabater-Molina, María
dc.contributor.authorPeñafiel Verdú, Pablo
dc.contributor.authorJiménez Jáimez, Juan 
dc.contributor.authorRodríguez Mañero, Moisés
dc.contributor.authorBrion, María
dc.date.accessioned2024-11-20T08:37:31Z
dc.date.available2024-11-20T08:37:31Z
dc.date.issued2022-03-01
dc.identifier.citationMartínez Campelo, L. et. al. PLoS ONE 17(3): e0263469. [https://doi.org/10.1371/journal.pone.0263469]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/97123
dc.description.abstractIn Brugada syndrome, even within the same family where all affected individuals share the same mutation, phenotypic variation is prominent, with variable penetrance and expressivity, presenting different degrees of involvement. It is difficult to establish a direct correlation between genotype and phenotype to predict prognosis in complications and risk of sudden death. The factors that modulate this inter- and intra-familial phenotypic variability remain to be determined. With the intention of testing whether other genetic factors, in addition to the causal mutation in SCN5A, may have a modulating effect on the Brugada phenotype and the risk of sudden death, we have studied 8 families with a causal variant in SCN5A with at least two affected individuals, one of whom has suffered cardiac arrest or sudden death. Whole exome sequencing was performed looking for additional variants that modify the phenotype and allow us to predict a better or worse prognosis for the evolution of the disease. The results did not show any clear genetic modifier; nevertheless, highlight the possible implication of the cholesterol and fibrosis pathways, as well as the circadian rhythm, as possible modulators of Brugada syndrome phenotype.es_ES
dc.description.sponsorshipConvocatoria de Ayudas a la Investigación en Salud de la Fundación Mutua Madrileñaes_ES
dc.description.sponsorshipPlan Estatal de I+D+i 2013-2020, Subdirección General de Evaluación y Fomento de la Investigación (ISCIII-SGEFI) from Instituto de Salud Carlos III (ISCIII)es_ES
dc.description.sponsorshipFondo Europeo de Desarrollo Regional (FEDER) (grant numbers PI19/01283, CB16/11/00226)es_ES
dc.description.sponsorshipPFIS scholarship from the Instituto de Salud Carlos III (ISCIII) and Fondo Europeo de Desarrollo Regional (FEDER)(grant number FI20/00191)es_ES
dc.language.isoenges_ES
dc.publisherPLOS ONEes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleSearching for genetic modulators of the phenotypic heterogeneity in Brugada syndromees_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1371/journal.pone.0263469
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Atribución 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Atribución 4.0 Internacional